National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings, 81924 [2024-23355]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
81924
Federal Register / Vol. 89, No. 196 / Wednesday, October 9, 2024 / Notices
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mariam Zaka, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1009J,
Bethesda, MD 20892, (301) 435–1042,
zakam2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
HEAL Initiative Advanced Postdoctoral-toIndependent Career Transition Award in
PAIN and SUD Research to Promote Diversity
Review.
Date: November 6, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Katherine M Malinda,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4140,
MSC 7814, Bethesda, MD 20892, (301) 435–
0912, malindakm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business Panel: Respiratory Sciences.
Date: November 6–7, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge, Drive
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Michael L Bloom, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6187,
MSC 7804, Bethesda, MD 20892, 301–451–
0132, bloomm2@mail.nih.gov.
Name of Committee: Infectious Diseases
and Immunology B Integrated Review Group;
Bacterial-Host Interactions Study Section.
Date: November 6–7, 2024.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Uma Basavanna, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 827–1398, uma.basavanna@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Aging, Neurodegeneration, and
Neurotoxicology.
Date: November 6–7, 2024.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: M. Catherine Bennett,
Ph.D., Scientific Review Officer, Center for
VerDate Sep<11>2014
17:05 Oct 08, 2024
Jkt 265001
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7846, Bethesda, MD 20892, 301–435–
1766, bennettc3@csr.nih.gov.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Analytics and Statistics for Population
Research Panel B Study Section.
Date: November 6–7, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Victoriya Volkova, DVM,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20817, (301) 594–7781, volkovav2@
csr.nih.gov.
Dated: October 3, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–23354 Filed 10–8–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Interdisciplinary Team
Science to Uncover the Mechanisms of Pain
Relief by Medical Devices (RM1 Clinical
Trial Optional).
Date: November 7, 2024.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Name of Committee: National Institutes of
Health, Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Meeting Format: Virtual Meeting.
Contact Person: Nilkantha Sen, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH/DHHS, NSC, 6001 Executive
Blvd., Rockville, MD 20852, 301–496–9223,
nilkantha.sen@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS).
Dated: October 3, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–23355 Filed 10–8–24; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
National Institutes of Health
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Biologics Contract Review
Meeting.
Date: November 4, 2024.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Address: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Meeting Format: Virtual Meeting.
Contact Person: Mirela Milescu, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH/DHHS, NSC, 6001 Executive
Blvd., Rockville, MD 20852, 301–496–5720,
mirela.milescu@nih.gov.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Centers for Research in
Emerging Infectious Diseases (CREID)
Network (U01 Clinical Trial Not Allowed).
Date: November 6–8, 2024.
Time: 9:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3E70A,
E:\FR\FM\09OCN1.SGM
09OCN1
]]>Agencies
[Federal Register Volume 89, Number 196 (Wednesday, October 9, 2024)]
[Notices]
[Page 81924]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-23355]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; Biologics Contract Review
Meeting.
Date: November 4, 2024.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract proposals.
Address: National Institutes of Health, Neuroscience Center,
6001 Executive Boulevard, Rockville, MD 20852.
Meeting Format: Virtual Meeting.
Contact Person: Mirela Milescu, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural
Activities, NINDS/NIH/DHHS, NSC, 6001 Executive Blvd., Rockville, MD
20852, 301-496-5720, [email protected].
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; Interdisciplinary Team Science to
Uncover the Mechanisms of Pain Relief by Medical Devices (RM1
Clinical Trial Optional).
Date: November 7, 2024.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Name of Committee: National Institutes of Health, Neuroscience
Center, 6001 Executive Boulevard, Rockville, MD 20852.
Meeting Format: Virtual Meeting.
Contact Person: Nilkantha Sen, Ph.D., Scientific Review Officer,
Scientific Review Branch, Division of Extramural Activities, NINDS/
NIH/DHHS, NSC, 6001 Executive Blvd., Rockville, MD 20852, 301-496-
9223, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS).
Dated: October 3, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-23355 Filed 10-8-24; 8:45 am]
BILLING CODE 4140-01-P
